MIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational PD-1 / ...
Raja Shankar, VP of machine learning at IQVIA, discusses which AI capabilities sponsors are most likely to adopt first to ...
Sustained “boots-on-the-ground” community engagement, beyond digital recruitment campaigns, was positioned as a primary lever to improve trial equity and representation. Hesitancy to discuss diversity ...
Exact presentation times may be subject to change. About Ocular Therapeutix, Inc.Ocular Therapeutix, Inc. is a fully-integrated biopharmaceutical company committed to redefining the retina experience.
NEW ORLEANS, May 1, 2025 /PRNewswire/ -- LongueVue Capital ("LVC") is pleased to announce that its portfolio company, Summit Clinical Research ("Summit" or the "Company"), in partnership with Pinnacle ...
REDWOOD CITY, Calif. and MIAMI, June 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...
MELBOURNE, Australia and PRINCETON, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel ...
Management to Engage with Global Clinical Research Leaders Ahead of Phase 2a Trial of Concussion Treatment Sarasota, Fla., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results